Abstract:It is notorious that cancer cells alter their metabolism to adjust to harsh environments of hypoxia and nutritional starvation. Metabolic reprogramming most often occurs in the tumor microenvironment (TME). TME is defined as the cellular environment in which the tumor resides. This includes surrounding blood vessels, fibroblasts, immune cells, signaling molecules and the extracellular matrix (ECM). It is increasingly recognized that cancer cells, fibroblasts and immune cells within TME can regulate tumor progression through metabolic reprogramming. As the most significant proportion of cells among all the stromal cells that constitute TME, cancer-associated fibroblasts (CAFs) are closely associated with tumorigenesis and progression. Multitudinous studies have shown that CAFs participate in and promote tumor metabolic reprogramming and exert regulatory effects via the dysregulation of metabolic pathways. Previous studies have demonstrated that curbing the substance exchange between CAFs and tumor cells can dramatically restrain tumor growth. Emerging studies suggest that CAFs within the TME have emerged as important determinants of metabolic reprogramming. Metabolic reprogramming also occurs in the metabolic pattern of immune cells. In the meanwhile, immune cell phenotype and functions are metabolically regulated. Notably, immune cell functions influenced by metabolic programs may ultimately lead to alterations in tumor immunity. Despite the fact that multiple previous researches have been devoted to studying the interplays between different cells in the tumor microenvironment, the complicated relationship between CAFs and immune cells and implications of metabolic reprogramming remains unknown and requires further investigation. In this review, we discuss our current comprehension of metabolic reprogramming of CAFs and immune cells (mainly glucose, amino acid, and lipid metabolism) and crosstalk between them that induces immune responses, and we also highlight their contributions to tumorigenesis and progression. Furthermore, we underscore potential therapeutic opportunities arising from metabolism dysregulation and metabolic crosstalk, focusing on strategies targeting CAFs and immune cell metabolic crosstalk in cancer immunotherapy.

Tumour's Digest: Macrophage metabolism creates a barrier to T cells

Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy

The role of macrophages in the tumor microenvironment and tumor metabolism

Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy

Metabolism and macrophages in the tumor microenvironment

Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion

Macrophages as regulators of tumour immunity and immunotherapy

Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells

Metabolic reprograming of tumor-associated macrophages

Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?

Metabolism, metabolites, and macrophages in cancer

The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity

Macrophage barrier in the tumor microenvironment and potential clinical applications

Metabolic reprogramming in the immunosuppression of tumor-associated macrophages

Macrophages and Metabolic Reprograming in the Tumor Microenvironment

Nutrient sensing in macrophages linked to reorganized tumor vasculature

The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment

Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment